✦ LIBER ✦

Elderly breast cancer patients treated by conservative surgery alone and adjuvant tamoxifen: 15 years results of a prospective study

✍ Scribed by R. Giovanazzi; G. Martelli; R. Miceli; D. Piromalli; G. Vetrella; M. Greco

Book ID: 119598210
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 58 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70718-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elderly breast cancer patients treated b

Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen : Fifteen-year results of a prospective study

✍ Gabriele Martelli; Rosalba Miceli; Aurora Costa; Danila Coradini; Stefano Zurrid 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract ## BACKGROUND. In elderly patients with early breast cancer and a clinically clear axilla, axillary surgery, sentinel lymph node biopsy, and postoperative radiotherapy to the residual breast may not be necessary because of reduced life expectancy, effectiveness of hormone therapy in ac

A prospective study of conservative surg

A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer

✍ Stuart J. Schnitt; James Hayman; Rebecca Gelman; Timothy J. Eberlein; Susan M. L 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Disease-Free Survival Advantage of Weekl

Disease-Free Survival Advantage of Weekly Epirubicin Plus Tamoxifen Versus Tamoxifen Alone as Adjuvant Treatment of Operable, Node-Positive, Elderly Breast Cancer Patients: 6-Year Follow-up Results of the French Adjuvant Study Group 08 Trial

✍ Theriault, R.L. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 62 KB

396 Randomized controlled study comparin

396 Randomized controlled study comparing surgery alone, surgery plus tamoxifen, and surgery plus tegafur-uracil in patients with node-negative breast cancer: 5-year results from the Kanto cooperative study group of adjuvant chemo-endocrine therapy for breast cancer (ACETBC) of Japan

✍ M. Kusama; T. Ikeda; K. Enomoto; F. Kasumi; T. Tominaga; S. Haga; M. Fukuda; S. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Adjuvant six cycles of high-dose adriamy

Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose acmf with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study

✍ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views